Bone Loss clinical trials at UCSF

1 research study open to eligible people

Showing trials for

  • Denosumab to Prevent High-Turnover Bone Loss After Bariatric Surgery

    open to eligible people ages 25 years and up

    Bariatric surgery leads to bone loss and increases fracture risk. This study evaluates whether denosumab can prevent the high-turnover bone loss that occurs after Roux-en-Y Gastric Bypass (RYGB) and sleeve gastrectomy (SG) surgery.

    San Francisco, California and other locations

Our lead scientists for Bone Loss research studies include .

Last updated: